Two Dosing Regimens of Certolizumab Pegol in Patients With Active Rheumatoid Arthritis

OBJECTIVE: To investigate clinical efficacy and safety of 2 certolizumab pegol (CZP) maintenance dosing regimens plus methotrexate (MTX) in active rheumatoid arthritis (RA) patients achieving the American College of Rheumatology 20% improvement criteria (ACR20) after the CZP 200 mg every 2 weeks ope...

Descripción completa

Detalles Bibliográficos
Autores principales: Furst, D E, Shaikh, S A, Greenwald, M, Bennett, B, Davies, O, Luijtens, K, Staelens, F, Koetse, W, Bertin, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329409/
https://www.ncbi.nlm.nih.gov/pubmed/25302624
http://dx.doi.org/10.1002/acr.22496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329409/
https://www.ncbi.nlm.nih.gov/pubmed/25302624
http://dx.doi.org/10.1002/acr.22496

Ejemplares similares